Ignite Creation Date:
2024-07-17 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06489860
Status:
WITHDRAWN
Last Update Posted:
2024-07-08
First Post:
2024-03-05
Brief Title:
SARS-CoV-2 Safety Study for the Treatment of COVID-19
Sponsor:
DHA Coffee Co Ltd
Organization:
DHA Coffee Co Ltd
Study Overview
Official Title:
SARS-CoV-2 Safety Study for the Treatment of COVID-19
Status:
WITHDRAWN
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
My record is not overseen by an IRB I change the Overall Status to Withdrawn
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SARS-CoV-2
Brief Summary:
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to protect Telomere chromosomes to maintain Acid Deoxyribonucleic ADN Molecules
Detailed Description:
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to change and disappear defective cells in virus variants Covid-19 disease Pluripotent stem cells produced strong cells serve as a repair system replacing damaged cells defective cells and dead cells
CHEMISTRY
SARS-CoV-2 does not use any chemicals no colors and no additives and no preservatives
Toxicology
SARS-CoV-2 product is not adverse effect non-toxic and no pharmacal toxicology
SARS-CoV-2 is not placebo drug
CHEMISTRY
SARS-CoV-2 does not use any chemicals no colors and no additives and no preservatives
Toxicology
SARS-CoV-2 product is not adverse effect non-toxic and no pharmacal toxicology
SARS-CoV-2 is not placebo drug
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None